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COMPETITION IN HEALTHCARE
Preliminary findings on competition in healthcare
should not be over-interpreted
Nick Black professor of health services research
London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
Research into the effects of competition on quality of care must
guard against the tendency to make over-optimistic claims of
benefits on the basis of initial findings.1
Despite the best attempts of excellent researchers, the three
existing studies in England are inevitably limited by their
reliance on routine administrative data (hospital episode
statistics; HES) and the need to make some heroic but dubious
assumptions (such as acute myocardial infarctions are “easily
clinically identifiable,” “adjusted mortality rates are purged of
case-mix”).2-4 These studies also mostly focus on one aspect of
quality—safety (hospital mortality rates and case fatality
rates)—and pay little attention to effectiveness, humanity
(experience), or equity.
The findings of these studies need to be interpreted more
cautiously. For example, the strongest evidence concerns acute
myocardial infarction case fatality rates.3 The key finding, a
dramatic decrease from 2002 to 2008, occurred in all hospitals
during a time when central policies such as the national service
framework and National Institute for Health and Clinical
Excellence guidelines were being implemented and additional
resources provided. If all methodological concerns are ignored,
the research shows that for a short period (2007) hospitals in
more competitive areas improved faster, although this was not
apparent in 2008. This suggests that, for one specific condition,
competition produced a marginal benefit, but it does not warrant
the claim of “death by market power.”2
If competition can help improve NHS quality, then research
must be conducted in other clinical areas using data that are not
subject to the limitations of HES. Until we have a clearer picture,
researchers should not encourage policymakers to over-interpret
interesting but preliminary findings.
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